SCHEMBL3394346

SCHEMBL3394346

CCOC(=O)c1cc(F)c(N2C[C@H](CF)[C@H](NC(=O)OC(C)(C)C)C2)c(C)c1F

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
OPRK1 P41145 4/20 0.31
RET P07949 2/20 0.31
USP30 Q70CQ3 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30
DRD2 P14416 1/20 0.30
DRD3 P35462 1/20 0.30
NR1H2 P55055 1/20 0.30
NR1H3 Q13133 1/20 0.30
KAT8 Q9H7Z6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3388781 0.90 MAPT (0.32) ALDH1A1USP30MAPTHTT
SCHEMBL3389887 0.90 USP30 (0.32) USP30
SCHEMBL2184090 0.90 USP30 (0.38) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL3388938 0.90 USP30 (0.32) KMT2AUSP30KAT8
SCHEMBL13968307 0.84 CYP2C19 (0.40) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL4520078 0.81 BTK (0.40) OPRK1DRD2DRD3
SCHEMBL13945284 0.81 KCNH2 (0.38) KMT2AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL3390398 0.81 KCNH2 (0.38) KMT2AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2184122 0.80 USP30 (0.38) ALDH1A1RETUSP30MAPTHTT
SCHEMBL13945279 0.79 MAOB (0.32) MEN1KMT2AALDH1A1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1857453-B1 FLUOROALKYLPYRROLIDINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2010-12-29 EP disclosed
EP-1857453-B1 FLUOROALKYLPYRROLIDINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2010-12-29 EP disclosed
US-20090012119-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-01-08 US disclosed
US-20090012119-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-01-08 US disclosed
US-20090012119-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1857453-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2007-11-21 EP disclosed
EP-1857453-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012119-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE FPR1, VIP, Q6ZSR9 MEN1 1274/4885KMT2A 1502/4885ALDH1A1 2123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.